Creo Medical Group PLC (LON:CREO – Get Free Report)’s stock price hit a new 52-week low during trading on Tuesday . The stock traded as low as GBX 21 ($0.27) and last traded at GBX 21.42 ($0.28), with a volume of 538148 shares trading hands. The stock had previously closed at GBX 22.35 ($0.29).
Creo Medical Group Trading Down 4.2 %
The firm has a fifty day moving average of GBX 27.49 and a 200 day moving average of GBX 31.92. The company has a debt-to-equity ratio of 13.88, a quick ratio of 2.19 and a current ratio of 3.83. The firm has a market capitalization of £77.49 million, a PE ratio of -357.00 and a beta of 0.86.
Creo Medical Group Company Profile
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
See Also
- Five stocks we like better than Creo Medical Group
- 3 Stocks to Consider Buying in October
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- AMD Gains Momentum With AI: Can It Beat Expectations?
- Investing in Commodities: What Are They? How to Invest in Them
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
